^
Association details:
| Biomarker: | PD-1 overexpression + CD8 positive |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug Class: | PD-L1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
4476 / 15 - PD-1 and TIGIT co-expression identifies a circulating CD8 T cell population predictive of response to anti-PD-1 therapy in melanoma and Merkel-cell carcinoma patients
Published date:
05/27/2020
Excerpt:
A population of PD-1high CD8 TILs was consequently described as predictive of PD-1 blockade in NSCLC.
